Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NEXANS ADR EO 1 | NXS0 | Nov 22, 2024 | 49.60 | -7.29 |
Nexans SA | NXS | Nov 22, 2024 | 107.00 | -1.74 |
NEXE Innovations Inc | NX5 | Nov 22, 2024 | 0.31 | +8.13 |
NexGen Energy Ltd | 6NE | Nov 22, 2024 | 8.50 | +6.28 |
NexGen Energy Ltd | 6NEA | Nov 22, 2024 | 7.70 | +4.05 |
NEXI S.P.A. Unsponsored ADR (Italy) | N0X0 | Nov 22, 2024 | 5.00 | 0.00 |
Nexi SpA | N0XA | Nov 22, 2024 | 5.27 | -3.30 |
Nexity SA | NQ9 | Nov 22, 2024 | 12.31 | +1.07 |
NEXLIVING CMNTYS INC. | NMX0 | Nov 22, 2024 | 1.43 | -0.69 |
Nexon Co Ltd | 7NX | Nov 22, 2024 | 13.30 | +3.10 |
NEXON CO.LTD ADR | 7NX0 | Nov 22, 2024 | 12.40 | +0.81 |
NexPoint Residential Trust, Inc. | 5O4 | Nov 22, 2024 | 42.60 | +1.43 |
NeXR Technologies SE | NXR | Nov 22, 2024 | 0.01 | -7.69 |
Nexstar Media Group, Inc. - Class A | NXZ | Nov 22, 2024 | 160.20 | +0.03 |
Nexstim | 5NX | Nov 22, 2024 | 5.00 | +1.83 |
NEXT Biometrics Group | NT7 | Nov 22, 2024 | 0.58 | +3.56 |
Next EQ | R87 | Nov 22, 2024 | 0.81 | -3.59 |
Next Fifteen Communications Group plc | 8LS | Nov 22, 2024 | 4.68 | +3.08 |
NEXT GEOSOLUTIONS EUROPE | LV8 | Nov 22, 2024 | 7.61 | -1.04 |
NEXT LS-,10 UNSP.ADR 1/2 | NXG0 | Nov 22, 2024 | 57.00 | +1.79 |
Next PLC | NXG | Nov 22, 2024 | 115.40 | +2.21 |
NextCell Pharma AB | 65G | Nov 22, 2024 | 0.11 | +2.77 |
NextCure, Inc. | 2US | Nov 22, 2024 | 1.22 | 0.00 |
NEXTDC Limited | 2NX | Nov 22, 2024 | 9.95 | +0.51 |
NextDecade Corporation | 2XD | Nov 22, 2024 | 6.84 | -1.27 |
NEXTECH3D.AI.CORP. O.N. | 1SS | Nov 22, 2024 | 0.04 | -6.28 |
Nextedia | 9KA | Nov 22, 2024 | 0.43 | -4.46 |
NEXTEER | 8NX | Nov 22, 2024 | 0.33 | -4.60 |
NextEnergy Solar Fund Limited | 5NE | Nov 22, 2024 | 0.76 | -1.30 |
NextEra Energy Inc | FP3 | Nov 22, 2024 | 74.41 | +0.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.